(Q46888787)

26 December 2017

title

Risk factors for post-ERCP pancreatitis: a prospective multicenter study (English)

1 reference

26 December 2017

author name string

Chi-Liang Cheng

1

1 reference

26 December 2017

Stuart Sherman

2

1 reference

26 December 2017

James L Watkins

3

1 reference

26 December 2017

Jeffrey Barnett

4

1 reference

26 December 2017

Martin Freeman

5

1 reference

26 December 2017

Joseph Geenen

6

1 reference

26 December 2017

Michael Ryan

7

1 reference

26 December 2017

Harrison Parker

8

1 reference

26 December 2017

James T Frakes

9

1 reference

26 December 2017

Evan L Fogel

10

1 reference

26 December 2017

William B Silverman

11

1 reference

26 December 2017

Kulwinder S Dua

12

1 reference

26 December 2017

Giuseppe Aliperti

13

1 reference

26 December 2017

Paul Yakshe

14

1 reference

26 December 2017

Michael Uzer

15

1 reference

26 December 2017

Whitney Jones

16

1 reference

26 December 2017

John Goff

17

1 reference

26 December 2017

Laura Lazzell-Pannell

18

1 reference

26 December 2017

Abdullah Rashdan

19

1 reference

26 December 2017

M'hamed Temkit

20

1 reference

26 December 2017

Glen A Lehman

21

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

26 December 2017

The American Journal of Gastroenterology

published in

1 reference

26 December 2017

volume

101

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

139-147

1 reference

26 December 2017

Adverse outcomes of ERCP.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Bedside scoring system to predict the risk of developing pancreatitis following ERCP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

The risk of determining risk with multivariable models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00380.X

10.1111/J.1572-0241.2006.00380.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16405547

1 reference

26 December 2017